Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$425K Hold
9,090
0.02% 188
2024
Q4
$466K Hold
9,090
0.03% 184
2024
Q3
$404K Hold
9,090
0.02% 177
2024
Q2
$365K Hold
9,090
0.02% 169
2024
Q1
$364K Hold
9,090
0.02% 173
2023
Q4
$342K Hold
9,090
0.02% 174
2023
Q3
$253K Buy
+9,090
New +$284K 0.02% 180
2014
Q2
Sell
-2,946
Closed -$70K 109
2014
Q1
$70K Sell
2,946
-143
-5% -$3.48K 0.01% 106
2013
Q4
$78K Buy
3,089
+143
+5% +$3.37K 0.01% 108
2013
Q3
$68K Sell
2,946
-527
-15% -$12K 0.01% 109
2013
Q2
$71K Buy
+3,473
New +$65.8K 0.01% 108

Other funds holding SNV

Sabal Trust's SNV Position: Q1 2025 in Review

Sabal Trust held its Synovus (SNV) position steady in Q1 2025 at 9,090 shares worth $425K. The position accounts for 0.02% of the portfolio, ranked #188.

Sabal Trust first reported a position in SNV in Q2 2013 and has held it in 11 quarters since. The position peaked at $466K in Q4 2024. 478 funds tracked by Wall St. Rank hold SNV as of Q1 2025.

  • Sabal Trust held 9,090 shares of Synovus worth $425K as of Q1 2025.
  • Sabal Trust left its Synovus share count unchanged in Q1 2025.
  • Synovus made up 0.02% of Sabal Trust's portfolio in Q1 2025, its #188 holding.
  • Sabal Trust first reported a position in Synovus in Q2 2013 and has held it in 11 quarters since.
  • Sabal Trust's Synovus position peaked at $466K in Q4 2024.
  • 478 funds tracked by Wall St. Rank held Synovus as of Q1 2025.

Based on Sabal Trust's 13F filing for Q1 2025, filed 23 Apr 2025.